Key points from article :
Dsuvia is a brand of sufentanil, a more potent version of fentanyl, made by company AcelRx.
An advisory committee of FDA rejected this drug in 2017 over safety concerns.
Following its resubmission in 2018, FDA excluded members of the drug safety committee from the hearing.
This is unethical manipulation of drug approval process in favour of big pharma.
Shows that FDA is willing to sacrifice American lives to this opioid epidemic.
Misuse of opioids killed many over the past 20 years and continues to claim about 150 lives a day.
Dr. Raeford Brown, chair of the committee of specialists advising FDA makes these accusations against FDA.
